- Inpatient and ambulatory haematology, bone marrow transplantation, consultative service to the Royal Adelaide Hospital and private practitioners. The Royal Adelaide Hospital Haematology Unit is the South Australian State Centre for adult allogeneic and unrelated bone marrow transplantation, and haemophilia and thalassaemia services.
- Clinical research for the advancement of medical knowledge and as a means of attracting high quality scientists, new technology, and new therapeutic agents to the State.
- Undergraduate and postgraduate teaching and training for the Royal Adelaide Hospital, and the Universities of Adelaide and South Australia and provision of training opportunities for overseas graduates.
Highlights of 2006
- Professor Junia Melo, Professor of Molecular Haematology, Department of Haematology, Imperial College, London, UK
- Dr Nigel Patton, Consultant Clinical & Laboratory Haematologist, Caterbury Health Laboratories, Christchurch, New Zealand
- Prof Armand Keating, Epstein Professor & Head, Princess Margaret Hospital/Ontario Cancer Institute, Toronto, Canada
- Professor John Harlan, Royal Adelaide Hospital 2006 Nimmo Professor, Clement A Finch Professor of Hematology and an Adjunct Professor of Pathology, University of Washington, Seattle, USA
As part of the integrated Royal Adelaide Hospital/Institute of Medical and Veterinary Science Haematology Service, the Unit participated in the 2006 Haematology Strategic Planning Initiative. We agreed that our aspirations are
- To deliver the best possible health outcome through patient care, diagnostic tests and therapeutic products.
- To develop better treatment for haematological diseases through research and development.
- To promote haematology through teaching and training.
- To attract and retain the best staff by providing an interesting and varied workplace.
To promote innovation and excellence in Haematology and to deal effectively with external issues and stakeholders we sought to
- Clarify the executive, operational, professional roles of individuals
- Differentiate between leadership and managerial support positions
- Define teams for decision making, monitoring, operation support and promotion
- Recognise the importance of staff recruitment and retention, and succession planning
The State Government approach to health care delivery is based on a regional model emanating from the Generational Health Review. In the area of cancers, this is further defined by the State Cancer Control Plan released early in 2006. It is therefore our top priority to ensure that the Clinical Haematology Unit delivers its service under these guidelines. One of the main focus of the Strategic Planning Process is to ensure that our Clinical Service is accessible, user-friendly, cost-effective and outcome orientated. Furthermore, it is critical that it has a holistic focus, incorporating the family and the primary health care sector.
The main changes to improve the Clinical Service are:
To encourage service and research excellence a number of programs were formed to provide leadership in focus areas including Leukaemia, Myeloma, Regenerative Medicine, Haemostasis and Thrombosis, Transplantation, Lymphoproliferative Disorders, Teaching and Training and Transfusion.
The day-to-day function of the Clinical Unit is now the responsibility of a Clinical Management Team which comprises of Sr Terri Ventrice, Dr Noemi Horvath, Dr Ian Lewis, Dr Nigel Patton and Professor L Bik To (Chair). Together with a newly created “Clinical Operation Manager” position, this team will focus on providing the best patient care by providing an up-to-date protocol management system, individualized patient scheduling, outcome audits and patient pathway analysis. This team will also be responsible for monitoring the budget and drug usage and incidents in the Unit and, jointly with the Haematology Units at The Queen Elizabeth Hospital and the Flinders Medical Centre, preparing for a Statewide Haematology Service.
The Haematology Division has funded a Clinical Pharmacist Project in the Clinical Unit through its Private Practice income. The aim was to evaluate whether a project pharmacist would reduce errors and drug costs. The finding after 12 months confirmed what other studies have found: that a clinical pharmacist significantly improves patient understanding of medications, lessens drug-related morbidity and cost by reducing adverse drug interactions and ensuring protocol adherence. From 2007 the RAH Cancer Centre has funded a fulltime pharmacist for the Clinical Unit.
We welcome Dr Nigel Patton who had extensive haematology experience in the United Kingdom and New Zealand with a background in clinical trials and laboratory studies.
Associate Professor Szu-Hee Lee left for a position in Sydney.
Clinical Title holders:
A. Boyce to CN Palliative care
|Current Chairperson of the Clinical Executive Team|
|Dr Ian Lewis|
|Phone:||8222 3022 (Office)|
|8222 3954 (Mobile)|
|Senior Haematology Consultant|
|Dr Nigel Patton|
|Speed Dial 1193|
|Clinical Nurse Consultant (Ward D6)|
|Sister Terry Ventrice|
|Phone:||8222 4580 (Ward D6)|
|Clinical Operations Manager|
|Mr Allan Hayward|
|Speed Dial 1228|